Patients Coming Off Slimming Medications Regain Weight Far More Rapidly Than Dieters

Illustration of medical syringe and weighing machine
Obesity treatment often requires long-term strategies.

A recent study indicates that people who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop conventional lifestyle plans.

Published data in a major medical journal demonstrates that while overweight people frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"People buying such medications need to be cognizant of the danger of fast weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

Such speed of recovery implies a return to pre-treatment mass in about 18 months.

Analyzing Therapies

The study, which looked at 37 of studies involving over 9,000 of participants, contrasted the results of the injectable medications with conventional dieting.

Scientists emphasize that individuals who lose weight through lifestyle changes alone usually see a slower creep back—around 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Experts suggest the way of the jabs accounts for the amplified regain.

The injections imitate a body's own chemical called GLP-1, which moderates appetite.

"Artificially providing the hormone levels far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement leads to hunger is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

The NHS recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Many experts argue that, due to the likelihood of relapse, the therapy should be considered long-term.

This opinion is supported by drug manufacturers, who say that the results "emphasize the long-term character of excess weight," akin to managing diseases like high blood pressure.

User Experiences

People who have come off the medication report a sudden return of hunger.

"It felt as if something that goes on and you're instantly starving," said an individual.

The struggle is exacerbated if users have not adopted lasting dietary or behavioural modifications during treatment.

Significant Interest

Survey data suggest that a significant number of people in the UK have used these injections in the last 12 months, with demand being substantial.

  • Use is more common among women compared to males.
  • The 40s and 50s age group shows the highest level of interest.
  • A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle changes.

Tracy Robertson
Tracy Robertson

Amber Voss is a seasoned journalist and content strategist with a passion for delivering impactful news stories.